Cardiotoxicity of the Anticancer Therapeutic Agent Bortezomib

Recent case reports provided alarming signals that treatment with bortezomib might be associated with cardiac events. In all reported cases, patients experiencing cardiac problems were previously or concomitantly treated with other chemotherapeutics including cardiotoxic anthracyclines. Therefore, i...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Nowis, Dominika, Mączewski, Michał, Mackiewicz, Urszula, Kujawa, Marek, Ratajska, Anna, Wieckowski, Mariusz R., Wilczyński, Grzegorz M., Malinowska, Monika, Bil, Jacek, Salwa, Paweł, Bugajski, Marek, Wójcik, Cezary, Siński, Maciej, Abramczyk, Piotr, Winiarska, Magdalena, Dąbrowska-Iwanicka, Anna, Duszyński, Jerzy, Jakóbisiak, Marek, Golab, Jakub
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Investigative Pathology 2010
Assuntos:
Regular Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2877829/
https://ncbi.nlm.nih.gov/pubmed/20519734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/ajpath.2010.090690
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares